— Know what they know.
Not Investment Advice
Also trades as: IN.TO (TSX) · $vol 0M

INM NASDAQ

InMed Pharmaceuticals Inc.
1W: -3.6% 1M: -1.5% 3M: -17.4% YTD: +18.8% 1Y: -40.1% 3Y: -90.6% 5Y: -99.8%
$1.33
-0.02 (-1.48%)
 
Weekly Expected Move ±5.8%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $7.3M mcap · 4M float · 17.38% daily turnover · Short 20% of daily vol

📊 Key Metrics

TTM
$2B
Revenue
+37942.8% YoY
$-13M
Net Income
-42.6% YoY
$-10M
Free Cash Flow
-30.5% YoY
14.9%
Gross Margin
-0.2%
Op. Margin
-0.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-129.6%
ROA-103.6%
ROIC732.1%

Valuation

P/E-0.4
P/B5.4
EV/EBITDA-0.5

Leverage

Debt/Equity0.00
Current Ratio1.37
Interest Cov.-982.5x

Quality Scores

Piotroski F3/9
Altman Z610.61
Beneish M757.14

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms